News releases

FRAMINGHAM, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder and Chief Executive Officer, Jason Krantz, and its Chief Financial Officer, Rick Booth,

First quarter revenue grew 36% year-over-year to $50.1 million FRAMINGHAM, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended

Founder & CEO Jason Krantz will become Executive Chairman FRAMINGHAM, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (Nasdaq: DH ), an industry leader in healthcare commercial intelligence, today announced that its Board of Directors has appointed Robert Musslewhite as the

FRAMINGHAM, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its first quarter ended March 31, 2022 financial results will be released on Thursday, May 5,

Expansive solution, built on Analytical Wizards technology, delivers data-agnostic analytics on-demand to life sciences customers FRAMINGHAM, Mass., March 16, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial intelligence, today announced the

FRAMINGHAM, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will present at two upcoming conferences: the Raymond James 43 rd Annual Institutional

Fourth quarter revenue grew 38% year-over-year to $46.3 million Full year 2021 revenue grew 40% to $166.2 million   FRAMINGHAM, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence,

FRAMINGHAM, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its fourth quarter and full year ended December 31, 2021 financial results will be released on

By iteratively analyzing and reporting on real-world data, life sciences organizations can quickly assess multiple market opportunities during therapy development FRAMINGHAM, Mass., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial